This systematic review investigated the efficacy and acceptability of valproate compared to that of placebo, lithium, carbamazepine, olanzapine and haloperidol in the treatment of acute episodes of bipolar disorder. Ten randomised studies were included in the review: all examined patients with mania. Valproate was more effective than placebo in the treatment of mania. There was no significant difference between efficacy in valproate and lithium or between valproate and carbamazepine, but there were fewer data on these comparisons and so these questions remain unanswered. The evidence suggests that valproate may be less effective in reducing manic symptoms than olanzapine but may cause less sedation and weight gain. There remains a need for more trials comparing medicines in treating all affective episodes.
Valproate for acutre mood episodes in bipolar disorder
21 January 2009
This record should be cited as:
Macritchie K, Geddes J, Scott J, Haslam DR, Silva de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD004052. DOI: 10.1002/14651858.CD004052
Assessed as up to date:
8 September 2002